Compass Cannabis Terminates Proposed Transaction With Isodiol

CALGARY, Alberta, May 03, 2018 (GLOBE NEWSWIRE) — 10330698 Canada Ltd. (dba Compass Cannabis Clinic, or “the Company”) has announced today that, pursuant to the terms of the binding letter agreement dated April 18, 2018 and between the Company and Isodiol International Inc. (“Isodiol”), it has terminated the proposed transaction whereby Isodiol would, after the completion of the transaction, have acquired 19.9% of the issued and outstanding shares of Compass. Accordingly, the transaction between the parties will not be proceeding.

Original press release

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter